Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score
Edeline, J., Blanc, J.-F., Campillo-Gimenez, B., Ma, Y.-T., King, J., Faluyi, O., Mathurin, J., Ghazi, S., Palmer, D.H., Meyer, T.
Published in European journal of cancer (1990) (01.11.2017)
Published in European journal of cancer (1990) (01.11.2017)
Get full text
Journal Article
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
Marthey, L., Sa-Cunha, A., Blanc, J. F., Gauthier, M., Cueff, A., Francois, E., Trouilloud, I., Malka, D., Bachet, J. B., Coriat, R., Terrebonne, E., De La Fouchardière, C., Manfredi, S., Solub, D., Lécaille, C., Thirot Bidault, A., Carbonnel, F., Taieb, J.
Published in Annals of surgical oncology (01.01.2015)
Published in Annals of surgical oncology (01.01.2015)
Get full text
Journal Article
Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib
Decaens, T., Barone, C., Assenat, E., Wermke, M., Fasolo, A., Merle, P., Blanc, J.-F., Grando, V., Bruns, R., Straub, J., Zhao, C., Faivre, S.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial
BOIGE, V, RAOUL, J.-L, PIGNON, J. P, BOUCHE, O, BLANC, J.-F, DAHAN, L, JOUVE, J.-L, DUPOUY, N, DUCREUX, M
Published in British journal of cancer (08.10.2007)
Published in British journal of cancer (08.10.2007)
Get full text
Journal Article
Hepatic angiosarcoma: A suggestive pattern of enhancement on dynamic MR imaging
Cassinotto, C, Rullier, A, Hocquelet, A, Blanc, J.-F, Trillaud, H
Published in Diagnostic and interventional imaging (01.03.2015)
Published in Diagnostic and interventional imaging (01.03.2015)
Get full text
Journal Article
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, Ghassan K, Meyer, Tim, Cheng, Ann-Lii, El-Khoueiry, Anthony B, Rimassa, Lorenza, Ryoo, Baek-Yeol, Cicin, Irfan, Merle, Philippe, Chen, YenHsun, Park, Joong-Won, Blanc, Jean-Frederic, Bolondi, Luigi, Klümpen, Heinz-Josef, Chan, Stephen L, Zagonel, Vittorina, Pressiani, Tiziana, Ryu, Min-Hee, Venook, Alan P, Hessel, Colin, Borgman-Hagey, Anne E, Schwab, Gisela, Kelley, Robin K
Published in The New England journal of medicine (05.07.2018)
Published in The New England journal of medicine (05.07.2018)
Get full text
Journal Article
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.
Published in Oncoimmunology (2019)
Published in Oncoimmunology (2019)
Get full text
Journal Article
Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy
Duc, S., Rainfray, M., Soubeyran, P., Fonck, M., Blanc, J. F., Ceccaldi, J., Cany, L., Brouste, V., Mathoulin‐Pélissier, S.
Published in Psycho-oncology (Chichester, England) (01.01.2017)
Published in Psycho-oncology (Chichester, England) (01.01.2017)
Get full text
Journal Article
Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Prognosis, efficacy, and safety by liver disease etiology
Okusaka, T., Blanc, J.-F., Chau, I., Yang, L., Abada, P., Zhu, A.X.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC)
Decaens, T., Barone, C., Assenat, E., Wermke, M., Fasolo, A., Merle, P., Blanc, J.F., Grando, V., Bruns, R., Straub, J., Zhao, C., Faivre, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)
Zhu, A.X., Finn, R.S., Galle, P.R., Llovet, J.M., Blanc, J.F., Okusaka, T., Chau, I., Cella, D., Girvan, A., Gable, J., Bowman, L., Hsu, Y., Abada, P.B., Kudo, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety across two global randomized Phase 3 studies (REACH-2 and REACH)
Zhu, A., Finn, R., Galle, P., Llovet, J., Blanc, J F, Okusaka, T., Chau, I., Abada, P., Hsu, Y., Kudo, M.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
Blanc, J.F., Meyer, T., Cheng, A.-L., El-Khoueiry, A.B., Cicin, I., Chen, Y., Bolondi, L., Dadduzio, V., Baron, A., Lin, Z.-Z., Adriani, J., Kelly, R.K., Abou-Alfa, G.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma
Le Bail, Brigitte, Faouzi, Saadia, Boussarie, Liliane, Guirouilh, Josée, Blanc, Jean-Frédéric, Carles, Jacques, Bioulac-Sage, Paulette, Balabaud, Charles, Rosenbaum, Jean
Published in The Journal of pathology (01.09.1999)
Published in The Journal of pathology (01.09.1999)
Get full text
Journal Article
Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres
Martin, M., Hocquelet, A., Debordeaux, F., Bordenave, L., Blanc, J.-F., Papadopoulos, P., Lapuyade, B., Trillaud, H., Pinaquy, J.-B.
Published in Diagnostic and interventional imaging (01.01.2021)
Published in Diagnostic and interventional imaging (01.01.2021)
Get full text
Journal Article
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumor classification
Calderaro, J, Couchy, G, Imbeaud, S, Amaddeo, G, Blanc, J.-F, Laurent, C, Hajji, Y, Azoulay, D, Bioulac-Sage, P, Zucman-Rossi, J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management
Abouhammoud, A, Henriet, E, Dupuy, J.-W, Dartigues, B, Ezzoukhry, Z, Senant, N, Blanc, J.-F, Lebail, B, Nikolski, M, Bioulac-Sage, P, Balabaud, C, Raymond, A.-A, Saltel, F
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Chen, L.-T., Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G.S., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J.-F., Hubner, R., Chiu, C.-F., Schwartsmann, G., Braiteh, F., Belanger, B., Bayever, E., de Jong, F., von Hoff, D.D., Siveke, J.T.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Analysis of serum biomarkers (BM) in patients (pts) from a phase 3 study of lenvatinib (LEN) vs sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC)
Finn, R.S., Kudo, M., Cheng, A-L., Wyrwicz, L., Ngan, R., Blanc, J-F., Baron, A.D., Vogel, A., Ikeda, M., Piscaglia, F., Han, K-H., Qin, S., Minoshima, Y., Funahashi, Y., Ren, M., Dairiki, R., Sachdev, P., Tamai, T., Dutcus, C., Evans, T.R.J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article